Edition: International | Greek
MENU

Home » EU Actually

European Commission vaccine competence?

With vaccination campaigns in EU member states stalled because there is not enough of approved vaccines, vaccination in the United Kingdom is going fast, due to the urgence of the situation

By: N. Peter Kramer - Posted: Thursday, January 7, 2021

"The faster rate at which the UK, Israel and the US are vaccinating is increasing pressure on EU governments and particularly the European Commission, which is coordinating the joint EU vaccine strategy."
"The faster rate at which the UK, Israel and the US are vaccinating is increasing pressure on EU governments and particularly the European Commission, which is coordinating the joint EU vaccine strategy."

by N. Peter Kramer

With vaccination campaigns in EU member states stalled because there is not enough of approved vaccines, vaccination in the United Kingdom is going fast, due to the urgence of the situation. The faster rate at which the UK, Israel and the US are vaccinating is increasing pressure on EU governments and particularly the European Commission, which is coordinating the joint EU vaccine strategy. This joint EU approach intended to benefit the member states is showing the weakness of the Commission quite clearly. Markus Soder, leader of Germany’s Christian Social Union (CSU), partner of Angela Merkel’s Christian Democratic Union (CDU), expressed this by saying: ‘The European Commission has planned too bureaucratically: too few of the right (vaccines) have been ordered and price debates have gone on for too long’. He added in an interview with Germany’s newspaper Bild am Sonnntag: “It is difficult to explain that a very good vaccine (that of Pfizer/BioNTech) has been developed in Germany but is administered more quickly outside the EU. The EU procurement procedure was inadequate’.

Soder refers to the more than one million UK residents which have already received this vaccine at this moment. The reason the British are ahead is that, like the Americans, they have chosen to issue temporary emergency permits. The British regulator explained that no vaccine would be approved for delivery in the UK if it failed to meet the expected safety, quality and efficacy standards’. EU member states also have the right to resort to an emergency permit, but they are still waiting for full market authorisation for the EU Medicines Agency (EMA). The AstraZeneca vaccine, which also plays a crucial position in the EU vaccine strategy, will not be available till mid-January.

The European Council decision to place the European Commission centre stage in the vaccine roll out was applauded at the time and encouraged by some as a step towards inclusion of Health in the EU ‘s remit. Now it seems as though the decision and subsequent delays may in fact hurt rather than help the europhile’s case.

READ ALSO

EU Actually

EU climate law agreement: Council did not give in

N. Peter KramerBy: N. Peter Kramer

Last night, the negotiators of the European Parliament and Council reached a provisional political agreement on the objective of a climate-neutral EU by 2050 and a collective net greenhouse gas emissions reduction target of at least 55% by 2030 compared to 1990

View 01-02/2021 2021 Digital edition

Magazine

Current Issue

01-02/2021 2021

View past issues
Subscribe
Advertise
Digital edition

Europe

Europe fit for the Digital Age

Europe fit for the Digital Age

Commission proposes new rules and actions for excellence and trust in Artificial Intelligence

Business

Li Shufu is pulling the strings at Volvo, Mercedes and Lotus

Li Shufu is pulling the strings at Volvo, Mercedes and Lotus

Will carmaker Volvo get a stock exchange listing in Stockholm, or may be in Amsterdam, as Bloomberg news agency claims?

MARKET INDICES

Powered by Investing.com
All contents © Copyright EMG Strategic Consulting Ltd. 1997-2021. All Rights Reserved   |   Home Page  |   Disclaimer  |   Website by Theratron